US Medical Eligibility Criteria for Contraceptive Use, 2016
US Medical Eligibility Criteria for Contraceptive Use, 2016
复制标题
DOI：
10.15585/mmwr.rr6503a1
复制
发表时间：
2016-07-29
影响因子：
33.7
通讯作者：
Whiteman, Maura K.
中科院分区：
文献类型：
--
作者：
Curtis, Kathryn M.;Tepper, Naomi K.;Whiteman, Maura K.
2016年美国避孕药具使用医疗资格标准（US. MEC）包括对具有某些特征或医疗条件的妇女和男子使用特定避孕方法的建议。CDC在对科学证据进行审查并与2015年8月26日至28日在格鲁吉亚亚特兰大举行会议的国家专家进行磋商后，对医疗保健提供者的这些建议进行了更新。本报告中的信息更新了2010年美国MEC（CDC。2010年美国避孕药使用的医疗资格标准。MMWR 2010：59 [No. RR-4]）。值得注意的更新包括增加了对囊性纤维化妇女、多发性硬化妇女和接受某些精神药物或圣约翰草的妇女的建议;对紧急避孕建议的修订，包括增加醋酸乌利司他;对产后妇女的建议的修订;已知患有血脂异常、偏头痛、浅表静脉疾病、妊娠滋养细胞疾病、性传播疾病和人类免疫缺陷病毒的女性;以及正在接受抗逆转录病毒治疗的女性。本报告中的建议旨在帮助卫生保健提供者就避孕方法的选择向妇女、男子和夫妇提供咨询。虽然这些建议旨在作为临床指导的来源，但卫生保健提供者应始终考虑每个寻求计划生育服务的人的个人临床情况。本报告并非旨在替代个别患者的专业医疗建议。人们在考虑计划生育方案时应征求其保健提供者的意见。
The 2016 U.S. Medical Eligibility Criteria for Contraceptive Use (US. MEC) comprises recommendations for the use of specific contraceptive methods by women and men who have certain characteristics or medical conditions. These recommendations for health care providers were updated by CDC after review of the scientific evidence and consultation with national experts who met in Atlanta, Georgia, duringAugust 26-28, 2015. The information in this report updates the 2010 U.S. MEC (CDC. U.S. medical eligibility criteria for contraceptive use, 2010. MMWR 2010:59 [No. RR-4]). Notable updates include the addition of recommendations for women with cystic fibrosis, women with multiple sclerosis, and women receiving certain psychotropic drugs or St. John's wort; revisions to the recommendations for emergency contraception, including the addition of ulipristal acetate; and revisions to the recommendations for postpartum women; women who are breaseeding; women with known dyslipidemias, migraine headaches, superficial venous disease, gestational trophoblastic disease, sexually transmitted diseases, and human immunodeficiency virus; and women who are receiving antiretroviral therapy. The recommendations in this report are intended to assist health care providers when they counsel women, men, and couples about contraceptive method choice. Although these recommendations are meant to serve as a source of clinical guidance, health care providers should always consider the individual clinical circumstances of each person seeking family planning services. This report is not intended to be a substitute for professional medical advice for individual patients. Persons should seek advice from their health care providers when considering family planning options.